FIELD: pharmacology.
SUBSTANCE: invention relates to 2-[5-(2-chloro-4-methylphenyl)-4-phenyl-4H-[1,2,4]trisol-3-ylmercapto]-N-(3,5-dimethylphenyl)acetamide with the structural formula (I):
. The invention also relates to compound application, to a pharmaceutical composition, to a dosage form, to a method for flu prevention or treatment.
EFFECT: new compound is obtained that has selective antiviral activity against strains of influenza A.
10 cl, 1 dwg, 1 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TRIAZOLE DERIVATIVES | 2006 |
|
RU2416605C2 |
| COMPOUNDS WITH LYSOSOMOTROPIC AND ANTIVIRAL ACTIVITY | 2021 |
|
RU2817947C2 |
| PHARMACEUTICAL COMPOSITION FOR CANCER AND VIRAL DISEASE TREATMENT, METHOD OF CANCER TREATMENT, METHOD OF VIRAL INFECTION TREATMENT BASED ON THEREOF | 1996 |
|
RU2177316C2 |
| 1,3-DIOXOINDENE DERIVATIVES, THEREOF PHARMACEUTICALLY ACCEPTABLE SALT, METHOD OF OBTAINING THEREOF AND PHARMACEUTICAL ANTIVIRAL COMPOSITION, CONTAINING IT AS ACTIVE INGREDIENT | 2012 |
|
RU2566761C2 |
| SUBSTITUTED ARYLSULFONAMIDES AS ANTIVIRAL AGENTS | 2007 |
|
RU2423352C2 |
| VETERINARY ANTIVIRAL DRUG | 2014 |
|
RU2561674C1 |
| PHARMACEUTICAL COMPOSITION (VARIANTS), DERIVATIVES OF 3,5-DIPHENYL-1,2,4-TRIAZOLES COMPRISING THEREOF | 1997 |
|
RU2208010C2 |
| METHOD OF PRODUCTION OF ANTI-VIRAL DRUG | 2017 |
|
RU2747082C2 |
| ACIDYLATED HETEROARYLCONDENSED CYCLOALKENYLAMINES AND THEIR USE AS PHARMACEUTICAL AGENTS | 2003 |
|
RU2338743C2 |
| AMID DERIVATIVE | 2004 |
|
RU2336273C2 |
